An updated meta-analysis of randomized controlled trials of everolimus- versus paclitaxel-eluting stents

International Journal of Cardiology

Volumn 151, Issue 3, 2011, Pages 354-355

  Takagi, Hisato ^a   Umemoto, Takuya ^a  

^a SHIZUOKA MEDICAL CENTER   (Japan)

Author keywords

Everolimus eluting stent; Meta analysis; Paclitaxel eluting stent; Randomized controlled trial

Indexed keywords

EVEROLIMUS; PACLITAXEL;

CORONARY STENT; DRUG ELUTING STENT; HEART INFARCTION; HUMAN; LETTER; META ANALYSIS (TOPIC); PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); STENT THROMBOSIS;

EID: 80052710225     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.05.086     Document Type: Article

References (12)

1. Cassese S, Piccolo R, Galasso G, De Rosa R, Piscione F. Twelve-month clinical outcomes of everolimus-eluting stent as compared to paclitaxel- and sirolimus- eluting stent in patients undergoing percutaneous coronary interventions. A meta-analysis of randomized clinical trials. Int J Cardiol in press [Epub ahead of print].
2. E. Kedhi, K.S. Joesoef, and E. McFadden Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial Lancet 375 2010 201 209
3. R.A. Byrne, A. Kastrati, and S. Kufner Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial Eur Heart J 30 2009 2441 2449
4. P.N. Ruygrok, M. Desaga, and F. Van Den Branden One year clinical follow-up of the XIENCE V Everolimus-eluting stent system in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II study EuroIntervention 3 2007 315 320
5. G.W. Stone, M. Midei, and W. Newman Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial JAMA 299 2008 1903 1913 (Pubitemid 351574920)
6. G.W. Stone, A. Rizvi, and W. Newman Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease N Engl J Med 362 2010 1663 1674
7. Smits PC, Kedhi E, Royaards KJ, et al. 2-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice The COMPARE (Comparison of the everolimus eluting XIENCE-V stent with the paclitaxel eluting TAXUS LIBERTÉ stent in all-comers: a randomized open label trial) Trial. J Am Coll Cardiol in press [Epub ahead of print].
8. H. Otake, J. Ako, and M. Yamasaki Comparison of everolimus- versus paclitaxel-eluting stents implanted in patients with diabetes mellitus as evaluated by three-dimensional intravascular ultrasound analysis Am J Cardiol 106 2010 492 497
9. S. Garg, P.W. Serruys, K. Miquel-Hebert On behalf of the SPIRIT II Investigators Four-year clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: The SPIRIT II trial Catheter Cardiovasc Interv 77 2011 1012 1017
10. R.J. Applegate, M. Yaqub, and J.B. Hermiller Long-term (three-year) safety and efficacy of everolimus-eluting stents compared to paclitaxel-eluting stents (from the SPIRIT III Trial) Am J Cardiol 107 2011 833 840
11. Stone GW, Rizvi A, Sudhir K, et al. Randomized Comparison of Everolimus- and Paclitaxel-Eluting Stents 2-Year Follow-Up From the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV Trial. J Am Coll Cardiol in press [Epub ahead of print].
12. L.G. Shewan, and A.J. Coats Ethics in the authorship and publishing of scientific articles Int J Cardiol 144 2010 1 2